ST Germain D J Co. Inc. boosted its position in MetLife, Inc. (NYSE:MET – Free Report) by 296.3% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,197 shares of the financial services provider’s stock after buying an additional 3,138 shares during the quarter. ST Germain D J Co. Inc.’s holdings in MetLife were worth $344,000 at the end of the most recent quarter.
Other institutional investors have also recently added to or reduced their stakes in the company. Dimensional Fund Advisors LP raised its stake in shares of MetLife by 22.4% in the 2nd quarter. Dimensional Fund Advisors LP now owns 5,396,274 shares of the financial services provider’s stock valued at $378,799,000 after purchasing an additional 988,666 shares in the last quarter. Legal & General Group Plc boosted its holdings in shares of MetLife by 5.4% in the second quarter. Legal & General Group Plc now owns 5,299,800 shares of the financial services provider’s stock valued at $371,993,000 after acquiring an additional 269,246 shares in the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its holdings in shares of MetLife by 1.5% in the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 4,548,725 shares of the financial services provider’s stock valued at $375,179,000 after acquiring an additional 68,579 shares in the last quarter. Nordea Investment Management AB boosted its holdings in MetLife by 16.8% during the fourth quarter. Nordea Investment Management AB now owns 4,238,087 shares of the financial services provider’s stock worth $347,735,000 after buying an additional 608,224 shares in the last quarter. Finally, Envestnet Asset Management Inc. boosted its holdings in MetLife by 3.2% during the second quarter. Envestnet Asset Management Inc. now owns 3,224,930 shares of the financial services provider’s stock worth $226,358,000 after buying an additional 100,782 shares in the last quarter. Institutional investors and hedge funds own 94.99% of the company’s stock.
Analysts Set New Price Targets
A number of brokerages recently weighed in on MET. Barclays raised their target price on shares of MetLife from $90.00 to $96.00 and gave the stock an “overweight” rating in a report on Monday, January 6th. StockNews.com downgraded shares of MetLife from a “buy” rating to a “hold” rating in a research report on Thursday. Jefferies Financial Group upped their price target on shares of MetLife from $89.00 to $95.00 and gave the company a “buy” rating in a research report on Friday, September 27th. JPMorgan Chase & Co. upped their price target on shares of MetLife from $86.00 to $88.00 and gave the company an “overweight” rating in a research report on Tuesday. Finally, Wells Fargo & Company upped their price target on shares of MetLife from $92.00 to $93.00 and gave the company an “overweight” rating in a research report on Tuesday, November 5th. One investment analyst has rated the stock with a hold rating and twelve have issued a buy rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $90.00.
MetLife Stock Down 3.0 %
MET stock opened at $80.30 on Friday. MetLife, Inc. has a 12-month low of $64.61 and a 12-month high of $89.05. The company has a quick ratio of 0.16, a current ratio of 0.16 and a debt-to-equity ratio of 0.51. The company has a market cap of $55.60 billion, a price-to-earnings ratio of 16.19, a PEG ratio of 0.76 and a beta of 1.07. The company has a 50 day moving average of $82.97 and a two-hundred day moving average of $78.92.
MetLife Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Tuesday, March 11th. Stockholders of record on Tuesday, February 4th will be paid a dividend of $0.545 per share. The ex-dividend date is Tuesday, February 4th. This represents a $2.18 annualized dividend and a dividend yield of 2.71%. MetLife’s dividend payout ratio (DPR) is 43.95%.
MetLife Company Profile
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
See Also
- Five stocks we like better than MetLife
- Investing in Commodities: What Are They? How to Invest in Them
- Driving Forward: Lucid’s Growing Sales and Gravity SUV’s Impact
- 3 Dividend Kings To Consider
- Why Amazon’s Next Earnings Could Trigger a Stock Breakout
- What is the Dogs of the Dow Strategy? Overview and Examples
- With This Kind of Data, The Fed Isn’t Cutting Rates This Year
Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET – Free Report).
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.